SU 88

Known as: SU-88 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-1986
012319821986

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
A study was made on the therapeutic effects of sofalcone (SU-88), an antiulcer agent, on erosive and atrophic gastritis induced… (More)
Is this relevant?
1986
1986
A study was made on changes in the gastric mucosal prostaglandin (PGE2) at the time of onset of stress ulcer in view of the… (More)
Is this relevant?
1985
1985
The biosynthesis of rat gastric glycoproteins with or without sulfate was investigated in rats subjected to restraint and water… (More)
Is this relevant?
1984
1984
SU-88 [2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone] inhibited the activity of the prostaglandin (PG)-metabolizing… (More)
Is this relevant?
1984
1984
2'-Carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy) chalcone (SU-88) has an anti-ulcer effect which is considered to increase the… (More)
Is this relevant?
1984
1984
The gastric cytoprotective action of SU-88, an anti-ulcer agent, was studied in rats. SU-88 dose-dependently prevented the… (More)
Is this relevant?
1983
1983
Effect of 2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy)chalcone (SU-88), a new anti-ulcer drug, on gastric tissue blood flow… (More)
Is this relevant?
1982
1982
Effects of a newly synthetized anti-ulcer drug, 2'Carboxymethoxy-4,4'-bis(3-methyl-2-butenloxy)chalcone (SU-88), on gastric blood… (More)
Is this relevant?